---
figid: PMC3460047__12307_2012_107_Fig5_HTML
figtitle: Usually growth factors bind and activate EGFR on the cell membrane of cancer
  cells to stimulate the down-stream PI3K-Akt-mTOR and Ras-Raf-MEK pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3460047
filename: 12307_2012_107_Fig5_HTML.jpg
figlink: /pmc/articles/PMC3460047/figure/Fig5/
number: F5
caption: Usually growth factors bind and activate EGFR on the cell membrane of cancer
  cells to stimulate the down-stream PI3K-Akt-mTOR and Ras-Raf-MEK pathway. Gene transcriptions
  and cell viability are enhanced. However the lymphocytes and antibodies elicited
  by EGFR-based vaccine block the binding of growth factor and EGFR
papertitle: Cancer Microenvironment and Cancer Vaccine.
reftext: Zhen-Yu Ding, et al. Cancer Microenviron. 2012 Dec;5(3):333-344.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9490983
figid_alias: PMC3460047__F5
figtype: Figure
redirect_from: /figures/PMC3460047__F5
ndex: 40164cbc-dea3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3460047__12307_2012_107_Fig5_HTML.html
  '@type': Dataset
  description: Usually growth factors bind and activate EGFR on the cell membrane
    of cancer cells to stimulate the down-stream PI3K-Akt-mTOR and Ras-Raf-MEK pathway.
    Gene transcriptions and cell viability are enhanced. However the lymphocytes and
    antibodies elicited by EGFR-based vaccine block the binding of growth factor and
    EGFR
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Akt
  - Dsor1
  - Mtk
  - Mtor
  - Tor
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
